Gauging the behaviour of nanoparticles in the lung
Nature Biotechnology
November 8, 2010
The behaviour of nanoparticles in the body after they are deposited in the lungs is reported online in Nature Biotechnology this week. The findings may have implications for future drug delivery, and in the study of air pollution and cancer development.
John Frangioni, Akira Tsuda, and colleagues used near-infrared fluorescent imaging to track nanoparticles administered to the lungs of rats. They varied the chemical composition, size and surface charge of the nanoparticles in order to determine which properties affect the transport of nanoparticles into tissues and their subsequent clearance from the body. The team shows that non-positively charged particles smaller than 34 nanometres in diameter are rapidly transported to lymph nodes, and that nanoparticles smaller than six nanometres with equal positive and negative charge are quickly cleared from the body via the kidneys.
With regard to the health effects of environmental pollutants, this work helps to explain why certain nanoparticles are more toxic than others. It also suggests that the toxicity of nanoparticle pollutants could be reduced by chemical strategies to alter their size and charge.
doi: 10.1038/nbt.1696
Research highlights
-
May 12
Geoscience: Monitoring earthquakes at the speed of lightNature
-
May 4
Microbiology: Bacteriophage therapy helps treat multi-drug resistant infection in an immunocompromised patientNature Communications
-
Apr 27
Planetary science: Building blocks of DNA detected in meteoritesNature Communications
-
Apr 8
Health: Psilocybin use associated with lower risk of opioid addictionScientific Reports
-
Apr 5
Energy: Winterizing the Texan energy infrastructure pays off in the long termNature Energy
-
Mar 17
Neuroscience: Sample size matters in studies linking brain scans to behaviourNature